Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dream phenomena induced by chronic levodopa therapy.

B Sharf, C Moskovitz, M D Lupton

    Journal of Neural Transmission
    |January 1, 1978
    PubMed
    Summary

    Parkinsonian patients on levodopa therapy frequently experience drug-related dream phenomena, including vivid dreams, night terrors, and nightmares. These altered dream experiences appear linked to the duration of levodopa treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Diagnosis of cerebral embolism by transesophageal echocardiography].

    Harefuah·2000
    Same author

    The presence of lupus anticoagulant and anticardiolipin antibodies in patients undergoing long-term neuroleptic treatment.

    Journal of psychiatry & neuroscience : JPN·1999
    Same author

    Risperidone-induced rabbit syndrome.

    The British journal of psychiatry : the journal of mental science·1999
    Same author

    High association of anticardiolipin antibodies with psychosis.

    The Journal of clinical psychiatry·1998
    Same author

    Brain-stem trigeminal and auditory evoked potentials in multiple sclerosis: physiological insights.

    Electroencephalography and clinical neurophysiology·1996
    Same author

    Teaching tape for the motor section of the unified Parkinson's disease rating scale.

    Movement disorders : official journal of the Movement Disorder Society·1995

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Sleep Medicine

    Background:

    • Parkinson's disease is a neurodegenerative disorder affecting motor function.
    • Levodopa is a primary treatment for Parkinson's disease, often used with carbidopa.
    • Altered dream phenomena are potential side effects of dopaminergic medications.

    Purpose of the Study:

    • To investigate the occurrence and types of drug-related dream phenomena in Parkinsonian patients.
    • To explore the correlation between levodopa therapy duration and these dream phenomena.

    Main Methods:

    • A cohort of 88 Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy was studied.
    • Patients reported new-onset dream phenomena, classified into vivid dreams, night terrors, and nightmares.
    • Data on therapy duration was collected and analyzed.

    Main Results:

    • 30.7% (27 out of 88) of patients reported drug-related dream phenomena.
    • Three distinct types of dreams were identified: vivid dreams, night terrors, and nightmares.
    • A correlation was observed between the duration of levodopa therapy and the incidence of these dream phenomena.

    Conclusions:

    • Chronic levodopa or levodopa/carbidopa therapy is associated with a significant incidence of drug-related dream phenomena in Parkinsonian patients.
    • The duration of therapy may influence the likelihood of experiencing these altered dreams.
    • The precise mechanism underlying these dream disturbances requires further investigation.

    Related Experiment Videos